Position in ERAS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,250,847
-$659,177 QoQ
Shares Held
1,596,662
-13.6% QoQ
Ownership
0.456%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 257 holders
Holding Since
Sep 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,747,178,871 across 561 Biotechnology names. ERAS ranks #54 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in ERAS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,250,847 | 1,596,662 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $29,910,024 | 1,848,580 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $634,374 | 170,531 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $318,630 | 146,161 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $629,471 | 495,647 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $189,653 | 138,433 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $484,851 | 193,168 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $629,598 | 230,622 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $106,497 | 45,126 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $163,813 | 79,521 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $238,229 | 111,845 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $107,742 | 54,692 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $151,297 | 54,818 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $94,106 | 31,265 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $850,444 | 197,319 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $22,424 | 2,875 | Shares | Defined | 2022-11-10 | |
| 2021-12-31 | $117,301 | 7,529 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,384 | 725 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||